5870
S. Buscemi et al. / Tetrahedron 57 32001) 5865±5871
J20.8 Hz), 2157.78 *bd, 2F, J20.8 Hz). MS m/z: 356
*100) *M1), 287 *16), 246 *56), 176 *16), 149 *7). Anal.
Calcd for C16H16F4N4O: C, 53.93; H, 4.53; N, 15.72.
Found: C, 53.80; H, 4.40; N, 15.80.
*71), 117.*42), 44 *100). Anal. Calcd for C9H5F5N2O3: C,
38.04; H, 1.77; N, 9.86. Found: C, 38.20; H,1.90; N, 9.70.
A sample of 9 *0.13 g) was kept in an oil-bath at 1208C for
6 h. Chromatography of the residue returned starting
material *0.065 g; 50%) and gave 10 *0.040 g; 33%).
In a further experiment, soon after the irradiation the
photolysate was neutralized with few drops of hydrochloric
acid and then the solvent was removed. Chromatography of
the residue returned starting material *0.05 g; 10%), and
Acknowledgements
gave 3-*N-pyrrolidinyl)-5-penta¯uorophenyl-1,2,4-oxa-
diazole *6e) *0.15 g; 28%), 7e *0.08 g; 15%) and 8e
*0.24 g; 40%).
Financial support from Italian MURST within the National
Research Project `Fluorinated Compounds: Synthetic
Targets and Advanced Applications' is gratefully acknowl-
edged.
1
Compound 6e had mp 85±868C *from light petroleum). H
NMR *CDCl3): d 2.01 *t, 4H, J7.4 Hz), 3.49 *t, 4H,
J7.4 Hz). MS m/z: 305 *85) *M1), 287 *76), 258 *11),
195 *57), 117 *42), 68 *100). Anal. Calcd for
C12H8F5N3O: C, 47.22; H, 2.64; N, 13.77. Found: C,
47.30; H, 2.50; N, 13.90.
References
1. *a) Silvester, M. J. Aldrichimica Acta 1991, 24, 31. *b) Burger,
K.; Wucherpfennig, U.; Brunner, E. Adv. Heterocycl. Chem.
1994, 60, 1 and references cited therein. *c) Furin, G. G.
Target in Heterocyclic Systems, Attanasi, O. A., Spinelli, D.,
3.2.6. Irradiation of compound 4 in the presence of
morpholine. The photolysate was left to stand for 24 h,
and then neutralized with hydrochloric acid. After removal
of the solvent, chromatography of the residue returned start-
ing material *0.1 g; 20%), and gave 3-*N-morpholinyl)-5-
penta¯uorophenyl-1,2,4-oxadiazole *6f) *0.19 g; 35%) and
3-*N-morpholinyl)-5-*2,3,5,6-tetra¯uoro-4-N-morpholinyl-
phenyl)-1,2,4-oxadiazole *8f) *0.11 g; 17%).
Á
Eds.; Societa Chimica Italiana: Roma, 1998; Vol. 2, p 355.
2. *a) Vivona, N.; Buscemi, S. Heterocycles 1995, 41, 2095.
*b) Buscemi, S.; Vivona, N.; Caronna, T. J. Org. Chem.
1995, 60, 4096. *c) Buscemi, S.; Vivona, N.; Caronna, T.
J. Org. Chem. 1996, 61, 8397. *d) Vivona, N.; Buscemi, S.;
Asta, S.; Caronna, T. Tetrahedron 1997, 53, 12629.
*e) Buscemi, S.; Pace, A.; Vivona, N.; Caronna, T.; Galia,
A. J. Org. Chem. 1999, 64, 7028.
1
Compound 6f had mp 80±818C *from light petroleum). H
NMR *CDCl3): d 3.52 *t, 4H, J4.7 Hz), 3.80*t, 4H,
J4.7 Hz). MS m/z: 321 *17) *M1), 306 *24), 195 *61),
149 *100), 117 *30). Anal. Calcd for C12H8F5N3O2: C,
44.87; H, 2.51; N, 13.08. Found: C, 44.90; H, 2.50; N, 13.10.
3. Inter alia: *a) Borg, S.; Estenne-Bouhtou, G.; Luthman, K.;
Csoregh, I.; Hesselink, W.; Hacksell, U. J. Org. Chem. 1995,
60, 3112. *b) Young, J. R.; DeVita, R. J. Tetrahedron Lett.
1998, 39, 3931. *c) Hebert, N.; Hannah, A. L.; Sutton, S. C.
Tetrahedron Lett. 1999, 40, 1.
Compound 8f had mp 126±1288C *from light petroleum).
1H NMR *CDCl3): d 3.40±3.43 *m, 4H), 3.51±3.55 *m, 4H),
3.80±3.86 *m, 8H). 19F NMR *CDCl3): d 2138.49 *bd, 2F,
J21.3 Hz), 2157.85 *bd, 2F, J17.8 Hz). MS m/z: 388
*88) *M1), 374 *65), 262 *50), 204 *46), 117 *6), 86 *85),
56 *100). Anal. Calcd for C16H16F4N4O3: C, 49.49; H, 4.15;
N, 14.43. Found: C, 49.40; H, 4.10; N, 14.50.
4. See, e.g.: *a) Saunders, J.; Macleod, A. M.; Merchant, K.;
Showell, G. A.; Snow, R. J.; Street, L. J.; Baker, R.
J. Chem. Soc., Chem. Commun. 1988, 1618. *b) Saunders,
J.; Cassidy, M.; Freedman, S. B.; Harley, E. A.; Iversen,
L. L.; Kneen, C.; Macleod, A. M.; Merchant, K. J.; Snow,
R. J.; Baker, R. J. Med. Chem. 1990, 33, 1128. *c) Street,
L. J.; Baker, R.; Book, T.; Kneen, C. O.; Macleod, A. M.;
Merchant, K. J.; Showell, G. A.; Saunders, J.; Herbert, R. H.;
Freedman, S. B.; Harley, E. A. J. Med. Chem. 1990, 33, 2690.
*d) Watjen, F.; Baker, R.; Engelstoff, M.; Herbert, R.;
MacLeod, A.; Knight, A.; Merchant, K.; Moseley, J.;
Saunders, J.; Swain, C. J.; Wong, E.; Spinger, J. P. J. Med.
Chem. 1989, 32, 2282. *e) Orlek, B. S.; Blaney, F. E.; Brown,
F.; Clark, M. S. G.; Hadley, M. S.; Hatcher, J.; Riley, G. J.;
Rosenberg, H. E.; Wadsworth, H. J.; Wyman, P. J. Med.
Chem. 1991, 34, 2726. *f) Diana, G. D.; Volkots, D. L.;
Nitz, T. J.; Bailey, T. R.; Long, M. A.; Vescio, N.; Aldous,
S.; Pevear, D. C.; Dutko, F. J. J. Med. Chem. 1994, 37, 2421.
*g) Messer, Jr., W. S.; Abuh, Y. F.; Liu, Y.; Periyasamy, S.;
Ngur, D. O.; Edgar, M. A. N.; Zl-Assadi, A. A.; Sbeih, S.;
Dunbar, P. G.; Roknich, S.; Rho, T.; Fang, Z.; Ojo, B.; Zhang,
H.; Huzl III, J. J.; Nagy, P. I. J. Med. Chem. 1997, 40, 1230.
5. Buscemi, S.; Pace, A.; Vivona, N. Tetrahedron Lett. 2000, 41,
7977.
3.2.7. Irradiation of compound 4 in methanol. A solution
of compound 4 *0.5 g) in methanol *300 mL) was appor-
tioned in six quartz tubes and then irradiated for 1.5 h.
The photolysate was left to stand for 24 h and then the
solvent was removed. Chromatography of the residue,
besides some amounts of minor components *discarded),
returned starting material *0.115 g; 27%), and gave
3-methoxy-5-penta¯uorophenyl-1,2,4-oxadiazole
*10)
*colorless oil which solidi®ed under freezing) *0.020 g;
4%) and then the O-penta¯uorobenzoylamidoxime *9)
*0.25 g; 52%).
Compound 10 had 1H NMR *CDCl3) d 4.15 *s). MS m/z 266
*100) *M1), 208 *67), 195 *86), 181 *45), 117 *38). Anal.
Calcd for C9H3F5N2O2: C, 40.62; H, 1.14; N, 10.53. Found:
C, 40.50; H, 1.10; N, 10.40.
6. Buscemi, S.; Vivona, N.; Caronna, T. Synthesis 1995, 917.
7. *a) Clapp, L. B. Adv. Heterocycl. Chem. 1976, 20, 65.
*b) Kraatz, U. Houben-Weyl E 8c, Heteroarenes III/3, Georg
Thieme: Stuttgart, 1994; p 409.
Compound 9 had mp 102±1038C *from light petroleum): IR
1
3400, 3530, 1740 cm21. H NMR *DMSO-d6) d 3.75 *s,
3H), 6.64 *s, 2H). MS m/z 284 *3) *M1), 221 *16), 195